 Participants in this study will be randomly assigned to one of the following treatment groups: 1 PharmCAT; 2 the Med-eMonitorTM; or 3 standard treatment. Participants in Group 1 will receive weekly home visits from a case manager. These visits will specifically target medication adherence. Participants in Group 2 will use the Med-eMonitorTM device. Data recorded by the device will be sent electronically to study staff. Participants in Group 3 will keep the Med-eMonitorTM device in their homes throughout the study but will not use its medication reminder function. The device will record only when medication is taken. All participants will report to the study site at study entry and Months 4, 7, and 10 for measures of symptoms, functioning, social activities, and relationships. 